Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-25-110500
Filing Date
2025-11-12
Accepted
2025-11-12 17:05:00
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-11-12

Document Format Files

Seq Description Document Type Size
1 ARS tm2510950d2_ars.pdf ARS 2171916
  Complete submission text file 0001104659-25-110500.txt   2988977
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38410 | Film No.: 251474070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)